Trends transforming the future of obesity drug development
Trends transforming the future of obesity drug development | ICON plc
For decades, obesity treatment centred primarily on lifestyle modifications like diet, exercise and behavioural therapy. However, these methods ...
Anti-obesity drug development: Industry trends in 2024 | Gubra
Next-generation Weight Loss Drug Therapies · Innovative Monotherapies and Combination Therapies · Emerging Injectable Obesity Pharmacotherapies.
Transforming obesity: The advancement of multi-receptor drugs: Cell
For more than a century, physicians have searched for ways to pharmacologically reduce excess body fat. The tide has finally turned with ...
What is the future of GLP-1 trends - PwC
From molecules to milestones: Reinventing for the future of weight loss drugs · GLP-1s have revolutionized the treatment of obesity and can compel companies to ...
When the dust settles: The future shape of the obesity market - IQVIA
For the first time pharmacological interventions delivered meaningful weight loss of 15% or more, triggering extraordinary consumer-led demand.
Oral obesity therapies: Holding the key to the future - IQVIA
Oral anti-obesity pharmacotherapies offer many compelling advantages over injectables, and they will play a critical role in tackling the ...
Chasing Novo and Lilly: The obesity drugs that could challenge ...
Four years ago, a large clinical trial run by Novo Nordisk showed a drug called semaglutide helped people with obesity lose, on average, around ...
Transforming obesity: The advancement of multi-receptor drugs
For more than a century, physicians have searched for ways to pharmacologically reduce excess body fat. The tide has finally turned with ...
Beyond Ozempic: New GLP-1 drugs promise weight loss and health ...
Some of the experimental drugs may go beyond diabetes and weight loss, improving liver and heart function while reducing side effects such as muscle loss.
These Drugs Are Changing the Fight against Obesity | BU Today
The government approved Wegovy, containing semaglutide, for obesity in 2021 and Zepbound, containing tirzepatide, in November 2023. Insulin is a ...
Transforming obesity: The advancement of multi-receptor drugs
1R/GIPR co-agonists follows the chemical trend first developed in GLP-1R agonism with liraglutide and semaglutide to now achieve a much ...
Obesity Market Review - July 8, 2024 - Stifel
Future Directions in the Obesity Drug Market (2035 and Beyond) ... While the history of obesity drug development is littered with ...
Anti-obesity drugs will be 2024's defining trend
Anti-obesity drugs will be the most impactful trend of 2024, followed by personalised and precision medicine, immuno-oncology (IO) drug development.
Scaling Up the Impact of Obesity Drugs - Morgan Stanley
The global market for obesity drugs could increase by more than 15-fold by 2030 as their use expands beyond weight loss to treat a range of ...
Transformative Trends in Obesity Management and Drug Discovery
Market Dynamics: The success of #Wegovy and #Mounjaro has catalyzed a flurry of innovation. A surge of new entrants is reshaping the market, ...
GLP-1 medications and weight loss: Helping patients navigate ...
GLP-1 medications have become wildly popular to treat obesity. Professionals need to manage patient expectations, educate on safe usage, and leverage evidence- ...
The increase in appetite for obesity drugs | J.P. Morgan Research
Wegovy. Mounjaro. Zepbound. Originally developed to treat diabetes, these GLP-1 agonists — now also popularly known as obesity drugs — have been ...
Obesity: Six trials to watch over the next 12 months
The approval of Novo Nordisk's Wegovy in 2021 catapulted the landscape of obesity medications as companies race to develop other drugs which can ...
Anti-Obesity Drug Delivery Systems: Recent Progress and Challenges
By the year 2030, nearly 60% of the global population may be obese or overweight, which emphasizes a need for novel obesity treatments. Various traditional ...
GLP-1 drugs are reshaping bodies—and the economy
The fight against obesity in America hasn't been going great. Despite the efforts of doctors, nutritionists, and public health educators on ...